Tenny Mudianto

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Ravindra Uppaluri, Katie M. Campbell, Ann Marie Egloff et al. · Clinical Cancer Research · 2020 · 365 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti–PD-1 Resistance in Head and Neck Cancer

Liye Zhou, Tenny Mudianto, Xiaojing Ma et al. · Clinical Cancer Research · 2019 · 260 citations · Full text

Medicine, Immunology, Oncology +16

SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2

Lu Qiao, Jia Liu, Shuai Zhao et al. · Immunity · 2021 · 170 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression

Maria Rusan, Kapsok Li, Yvonne Li et al. · Cancer Discovery · 2017 · 141 citations · Full text

Medicine, Cancer Biology, Oncology +17

Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC).

Ravindra Uppaluri, Paul Zolkind, Tianxiang Lin et al. · Journal of Clinical Oncology · 2017 · 77 citations

Medicine, Oncology, Radiation Oncology +16